Puchkov M

Galvita AG, Basel, Switzerland.

3 papers

ArticleAyahuasca

Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study.

Egger K, Jareño Redondo J, Müller J +13

Europe PMC2025
ArticleAyahuasca

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial.

Mueller MJ, Aicher HD, Dornbierer DA +16

Europe PMC2024
ArticleAyahuasca

Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine.

Dornbierer DA, Marten L, Mueller J +11

Europe PMC2023